Wendy Dixon

Wendy Dixon

Directeur/Bestuurslid bij ARVINAS, INC.

Vermogen: 347 598 $ op 31-05-2024

68 jaar
Health Technology
Consumer Services
Finance

Profiel

Wendy L.
Dixon
currently works at Alkermes, Inc., as Independent Director from 2011, Zevra Therapeutics, Inc., as Independent Director from 2023, Arvinas, Inc., as Independent Director from 2020, Special Equestrians, Inc., as Director, and Great Meadow Consulting LLC, as President from 2009.
Dr. Dixon also formerly worked at Sesen Bio, Inc., as Chairman from 2016 to 2020, DENTSPLY International, Inc., as Director from 2005 to 2010, Incyte Corp., as Independent Director from 2011 to 2022, Orexigen Therapeutics, Inc., as Independent Director from 2010 to 2016, Furiex Pharmaceuticals, Inc., as Independent Director from 2012 to 2014, bluebird bio, Inc., as Independent Director from 2013 to 2021, Ardea Biosciences, Inc., as Director in 2011, Edimer Pharmaceuticals, Inc., as Director, Iovance Biotherapeutics, Inc., as Independent Director from 2022 to 2023, Alkermes Plc, as Independent Director from 2011 to 2022, Voyager Therapeutics, Inc., as Independent Director from 2017 to 2021, Black Diamond Therapeutics, Inc., as Independent Director from 2022 to 2024, Bristol Myers Squibb Co., as Chief Marketing Officer in 2009, Centocor, Inc., as Principal, Merck & Co., Inc., as Senior Vice President-Marketing USHH from 1996 to 2001, Osteotech, Inc., as Principal, West Pharmaceutical Services, Inc., as Principal, The Monitor Group, Inc., as Senior Advisor, and Smithkline & French Laboratories US, Inc., as Principal.
Dr. Dixon received her undergraduate degree, graduate degree, and doctorate degree from the University of Cambridge.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-03-2024 38 054 ( 0.07% ) 181 898 $ 31-05-2024
31-03-2024 5 000 ( 0.01% ) 165 700 $ 31-05-2024
13-05-2024 0 ( -.--% ) - $ 31-05-2024

Actieve functies van Wendy Dixon

BedrijvenFunctieBegin
ARVINAS, INC. Directeur/Bestuurslid 29-06-2020
ZEVRA THERAPEUTICS, INC. Directeur/Bestuurslid 25-04-2023
President 01-07-2009
Directeur/Bestuurslid -
Directeur/Bestuurslid 16-09-2011
Alle actieve functies van Wendy Dixon

Eerdere bekende functies van Wendy Dixon

BedrijvenFunctieEinde
BLACK DIAMOND THERAPEUTICS, INC. Directeur/Bestuurslid 10-04-2024
IOVANCE BIOTHERAPEUTICS, INC. Directeur/Bestuurslid 06-06-2023
ALKERMES PLC Directeur/Bestuurslid 07-07-2022
INCYTE CORPORATION Directeur/Bestuurslid 14-06-2022
░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Wendy Dixon in detail bekijken

Opleiding van Wendy Dixon

University of Cambridge Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Wendy Dixon in detail bekijken

Connecties

100 +

Eerstegraads connecties

25

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven11
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

INCYTE CORPORATION

Health Technology

MERCK & CO., INC.

Health Technology

WEST PHARMACEUTICAL SERVICES, INC.

Health Technology

ZEVRA THERAPEUTICS, INC.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

VOYAGER THERAPEUTICS, INC.

Health Technology

ARVINAS, INC.

Health Technology

BLACK DIAMOND THERAPEUTICS, INC.

Health Technology

ALKERMES PLC

Health Technology

Bedrijven in privébezit13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Smithkline & French Laboratories US, Inc.

Health Technology

Health Technology

Consumer Services

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Wendy Dixon